Evaluation of blood pressure variation in recovered COVID-19 patients at one-year follow-up: a retrospective cohort study

• DOI: 10.1186/s12872-024-03916-w
• Publication Date: 2024-05-07T10:02:09Z
• Authors: Pouria Azami; Reza Golchin Vafa; Reza Heydarzadeh; Mehrdad Sadeghi; Farhang Amiri; Alireza Azadian; Amin Khademolhoss...; Mina Yousefi; Mohammad Montaseri; Nazanin Hosseini; Seyed Ali Hosseini; Javad Kojuri
• Keywords: Angiology; 2019-20 coronavirus outbreak

Abstract Background Coronavirus disease 2019 (COVID-19) has various sequelae, one of which might be hypertension. We aimed to evaluate COVID-19’s impact on blood pressure (BP) in non-hospitalized patients at one-year follow-up. Method A total 7,950 consecutive COVID-19 regularly visiting our cardiology clinic were retrospectively screened. Patients’ electronic medical records including demographics, comorbidities, vital signs, treatments, and outcomes, reviewed by two physicians. Individuals with least BP measurement the three months preceding 12 or more following recovery included. levels before after compared using paired t-test. Results 5,355 confirmed (mean age 55.51 ± 15.38 years) Hypertension (56.9%) diabetes mellitus (34%) predominant 44.3% had prior major adverse cardiovascular events. Both systolic (126.90 20.91 vs. 139.99 23.94 mmHg, P < 0.001) diastolic (80.54 13.94 86.49 14.40 significantly higher post-COVID-19 pre-COVID-19. Notably, 456 (14%) hypertensive experienced exacerbated hypertension, while 408 (17%) developed new-onset overall 864 (16%) exacerbation new Linear regression analysis revealed that advanced age, smoking, previous events, predict increased ( 0.001). Conclusion raised long term patients, over one-sixth developing All should evaluated regarding BP, recovery, particularly those mentioned predictive factors. (clinicaltrial.gov: NCT05798208)